Ticker
VIVSCompany Name
VIVOSIM LABS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Capital Expenditure | Capital Expenditures Margin | Revenues |
---|---|---|---|
6/30/2025 | $ -8.99M | 0% | $ 142K |
3/31/2025 | $ -8.99M | 0% | $ 144K |
12/31/2024 | $ 13K | 10.66% | $ 122K |
9/30/2024 | $ 13K | 12.62% | $ 103K |
6/30/2024 | $ 27K | 36.99% | $ 73K |
3/31/2024 | $ 42K | 38.53% | $ 109K |
12/31/2023 | $ 204K | 84.3% | $ 242K |
9/30/2023 | $ 245K | 66.58% | $ 368K |
6/30/2023 | $ 337K | 75.73% | $ 445K |
3/31/2023 | $ 396K | 107.03% | $ 370K |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CapEx / Revenues
(=) CapEx %
CapEx % for VIVOSIM LABS INC is calculated as follows: CapEx [ $ -727K ] / Revenues [ $ 298K ]
(=) CapEx % [ 0% ]
Minimum
Dec 31, 2024
Maximum
Mar 31, 2023
Average
Median
filtered constituents | 2.85K |
---|---|
min | 0% |
max | 15.02% |
average | 3.47% |
median | 2.43% |
std | 3.27% |